[1]戢运春 王玮.阿托伐他汀联合依折麦布治疗早发冠心病急性心肌梗死临床研究[J].内科,2015,(01):8-10.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.03]
 JI Yun-chun,WANG Wei.Clinical observation on atorvastatin combined with ezetimibe for treatment of patients with early acute myocardial infarction[J].Internal Medicine of China,2015,(01):8-10.[doi:03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.03]
点击复制

阿托伐他汀联合依折麦布治疗早发冠心病急性心肌梗死临床研究()
分享到:

《内科》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2015年01期
页码:
8-10
栏目:
论著
出版日期:
2015-02-25

文章信息/Info

Title:
Clinical observation on atorvastatin combined with ezetimibe for treatment of patients with early acute myocardial infarction
文章编号:
1673-7768(2015)01-0008-03
作者:
戢运春1 王玮2
(1湖北省十堰市房县城关镇卫生院内科,房县442100;2湖北省十堰市太和医院心血管内科,十堰市442000)
Author(s):
JI Yun-chun1 WANG Wei2
(1Department of internal medicine, the Health Center of Hubei province Shiyan Fangxian Chengguan Town, Fangxian 442100, China;2Department of Cardiology,Taihe Hospital of Shiyuan, Shiyuan 442000,China)
关键词:
阿托伐他汀依折麦布冠心病急性心肌梗死
Keywords:
Atorvastatin Ezetimibe Coronary heart disease Acute myocardial infarction
分类号:
R 542.2+2
DOI:
03DOI:10.16121/j.cnki.cn45-1347/r.2015.01.03
文献标志码:
A
摘要:
目的观察阿托伐他汀联合依折麦布治疗早发冠心病急性心肌梗死的疗效及其安全性。方法选择早发冠心病急性心肌梗死患者48例,随机分为两组,每组24例,对照组给予阿托伐他汀治疗,20 mg/d,观察组于对照组治疗的基础上给予依折麦布治疗,10 mg/d,比较两组患者疗效及血脂指标、超敏C-反应蛋白(hs-CRP)、左室射血分数(LVEE)及内皮舒张功能(FMD)的变化。结果两组均无死亡病例,观察组患者复发性心绞痛1例;对照组血运重建3例,复发性心绞痛2例。观察组患者TC、TG、LDL-C水平分别为(3.2±0.3)mmol/L、(1.8±0.1)mmol/L、(2.0±0.2)mmol/L,均显著低于对照组(P<0.05)。观察组HDL-C水平为(1.5±0.2)mmol/L,显著高于对照组(P<0.05)。治疗后观察组患者hs-CRP水平为(1.9±0.3)mg/L,显著低于对照组(P<0.05);观察组患者LVEE及FMD水平均高于对照组(P<0.05)。两组患者不良反应发生率比较差异无统计学意义(P>0.05)。结论阿托伐他汀联合依折麦布应用于早发冠心病急性心肌梗死患者疗效较佳,血清总胆固醇、低密度脂蛋白胆固醇水平显著降低,且应用较为安全,具有临床推广价值。
Abstract:
ObjectiveTo observe the effect and safety of atorvastatin combined with ezetimibe for treatment of patients with early acute myocardial. Methods48 patients with early acute myocardial were randomly divided into two groups with 24 cases in each, the control group was given atorvastatin, 20 mg/d,while the observation group was given ezetimibe(10 mg/d )based on the control group, the curative effect, blood lipids, hs-CRP,LVEE and FMD were compared between the two groups after treatemt. ResultsThere was no death cases in the two groups ,the patients ofrecurrent angina pectoris of the two groups were 1 and 2 cases, respectively, 3 patients were revascularization in control group. The levels of TC, TG, LDL-C, hs-CRP in theobservation group were (3.2±0.3) mmol/L, (1.8±0.1) mmol/L, (2±0.2) mmol/L, (1.9±0.3) mg/L, respectively and which were significantly lower than those in the control group,(P<0.05). The level of HDL-C was (1.5±0.2) mmol/L in observation group which was significantly higher than that in control group (P<0.05); the levels of LVEE and FMD in observation group were higher than that in the control group(P<0.05). The incidence rate of adverse reactions between the two groups had no significant difference(P>0.05). ConclusionsAtorvastatin combined with ezetimibe can lower the level of serum total cholesterol and density lipoprotein cholesterol,which is useful and safe for treatment of patients with early acute myocardial,and worthy of popularization and application.

参考文献/References:

[1]吴亚男,陈魁,申泱泱,等.依折麦布联合瑞舒伐他汀对冠状动脉粥样斑块的影响[J].中国实用医刊,2014,41(10):57-59. [2]艾尼瓦尔.艾山.依折麦布对长期接受抗精神病药物治疗的精神病患者血脂的调节作用[J].中国医药,2014,9(4):550-553. [3]Xia J,Qu Y,Shen H,et al.Patients with stable coronary artery disease receiving chronic statin treatment who are undergoing noncardiac emergency surgery benefit from acute atorvastatin reload[J].Cardiology,2014,128(3):285-292. [4]罗萍,王丽霞,朱好辉,等.阿托伐他汀联合依折麦布对冠状动脉粥样硬化性心脏病患者颈动脉粥样硬化斑块的影响[J].中华实验外科杂志,2014,31(2):289-291. [5]王小芳,张金盈,李凌,等.依折麦布与瑞舒伐他汀联合应用对冠心病临界病变斑块面积的影响[J].中国实用医刊,2013,40(18):38-41. [6]Li X,Chen C,Gan F,et al.Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy:a single-center cohort study[J].BMC Cardiovasc Disord,2014,14(1):67. [7]冯志祥,冯天无.依折麦布联合辛伐他汀对经皮腔内冠状动脉介入术后低密度脂蛋白胆固醇和C反应蛋白水平的影响[J].中国基层医药,2013,20(10):1528-1530. [8]Jefferis BJ,Whincup PH,Lennon LT,et al.Physical activity in older men: longitudinal associations with inflammatory and hemostatic biomarkers, N-terminal pro-brain natriuretic peptide,and onset of coronary heart disease and mortality[J].J Am Geriatr Soc,2014,62(4):599-606. [9]吴春芳,贺维亚.阿托伐他汀钙对急性脑梗死患者血清hs-CRP和MMP-9水平的影响[J].中国实用医刊,2013,40(1):59-60. [10]崔仲华,张喜娟,李咏梅,等.代谢综合征患者辛伐他汀联合依折麦布降血脂治疗的评价[J].中国综合临床,2012,28(7):701-703. [11]岳喜平.氨氯地平联合阿托伐他汀钙治疗高血压并冠心病疗效观察[J].中国基层医药,2013,20(10):1515-1516. [12]刘爱华,王绪芳,韩桂云.脑钠肽和NT-Pro BNP检测在心力衰竭诊断中的意义[J].中国基层医药,2011,18(8):1038-1040.

相似文献/References:

[1]孙文静 徐戈*.不同剂量阿托伐他汀短期治疗对急性冠脉综合症患者PCI围手术期血浆sCD163的影响[J].内科,2014,(03):252.
 SUN Wen-jing,XU Ge*.The effect of different doses of short-term atorvastatin on the concentration of plasma sCD163 in patients with acute coronary syndrome during perioperative period of PCI[J].Internal Medicine of China,2014,(01):252.
[2]杨理.通心络胶囊联合阿托伐他汀治疗冠心病心绞痛36例疗效观察[J].内科,2014,(06):641.
 YANG Li.Observation on therapeutic effect of Tongxinluo capsule combined with atorvastatin in treating 36 cases of angina pectoris caused by coronary heart disease[J].Internal Medicine of China,2014,(01):641.
[3]孙虎.阿托伐他汀联合氯吡格雷治疗急性脑梗死的疗效及对血清hs-CRP的影响分析[J].内科,2015,(05):662.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.23]
 [J].Internal Medicine of China,2015,(01):662.[doi:DOI:10.16121/j.cnki.cn45-1347/r.2015.05.23]
[4]张树锋 段小嬿 关浩增 陈英.阿托伐他汀对老年高血压患者血脂hs-CRP、IL-6、TNF-α和血管内皮舒张功能的影响[J].内科,2013,(01):4.
 ZHANG Shu-feng,DUAN Xiao-yan,GUAN hao-zeng,et al.Effects of Atorvastatin on hs-CRP,IL-6,TNF-α and endothelium-dependent vasodilation in elderly patients with hypertension[J].Internal Medicine of China,2013,(01):4.
[5]郑涛.阿托伐他汀对急性脑梗死患者血清超敏C反应蛋白及白细胞介素-6的影响[J].内科,2013,(01):19.
 [J].Internal Medicine of China,2013,(01):19.
[6]王杨光 何文威 冯敏.服用阿托伐他汀对慢性心力衰竭患者血氨基末端脑钠素前体的影响[J].内科,2013,(02):129.
 [J].Internal Medicine of China,2013,(01):129.
[7]刘稳 杨崇河 刘义桥 王丽娟 刘福明.蚓激酶联合阿托伐他汀对急性脑梗死患者颈动脉斑块的影响[J].内科,2013,(04):347.
 LIU Wen,YANG Chong-he,LIU Yi-qiao,et al.Effect of lumbrokinase and atorvastatin on the carotid plaque in patients with acute cerebral infarction[J].Internal Medicine of China,2013,(01):347.
[8]杨志勇 张利苑 李红利.小剂量阿托伐他汀治疗高龄动脉硬化的临床效果及安全性观察[J].内科,2013,(06):570.
 [J].Internal Medicine of China,2013,(01):570.
[9]刘迪䶮 张武昌 张雄 罗汝琴.不同剂量阿托伐他汀对急性脑梗死患者高敏C反应蛋白、白细胞介素6、肿瘤坏死因子α的影响[J].内科,2012,(01):3.
 LIU Di-yan,ZHANG Wu-chang,ZHANG Xiong,et al.Influences of different doses of Atorvastatin on the serum levels of hs-CRP、IL-6 and TNF-α in acute cerebral infarction patients[J].Internal Medicine of China,2012,(01):3.
[10]赵茂林 卫训 罗素红.厄贝沙坦联合阿托伐他汀治疗原发性高血压80例临床研究[J].内科,2012,(01):5.
 ZHAO Mao-lin,WEI Xun,LUO Su-hong.Clinical research of erbesartan combined with atorvastatin in the treatment of 80 patients with primary hypertension[J].Internal Medicine of China,2012,(01):5.

备注/Memo

备注/Memo:
基金项目:湖北省十堰市2009年科学研究与开发计划项目(2009s41)
更新日期/Last Update: 2015-09-28